Acute safety and effects on mucociliary clearance of aerosolized uridine 5'-triphosphate +/- amiloride in normal human adults.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  American Journal of Respiratory and Critical Care Medicine

• Publication date

  1996-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1164/AJRCCM.154.1.8680683PMID 8680683
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of CNP in human airways: cGMP-mediated stimulation of ciliary beat frequency.

  1995cited by this paper
• Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy.

  1994cited by this paper
• Pathologic Apnea and Brief Respiratory Pauses in Preterm Infants: Relation to Sleep State

  1994cited by this paper
• Effect of extracellular ATP and UTP on fluid transport by human nasal epithelial cells in culture.

  1994cited by this paper
• Altered fluid transport across airway epithelium in cystic fibrosis.

  1993cited by this paper
• ATP and UTP increase secretion of bronchial inhibitor by human tracheal gland cells in culture.

  1993cited by this paper
• Airway responsiveness to adenosine 5'-monophosphate in chronic obstructive pulmonary disease is determined by smoking.

  1993cited by this paper
• The acute effect of ipratropium bromide bronchodilator therapy on cough clearance in COPD.

  1993cited by this paper
• Amiloride inhalation therapy in cystic fibrosis. Influence on ion content, hydration, and rheology of sputum.

  1993cited by this paper
• Adenosine in bronchoalveolar lavage fluid in asthma.

  1993cited by this paper
• Nucleotide regulation of goblet cells in human airway epithelial explants: normal exocytosis in cystic fibrosis.

  1993cited by this paper
• An overview of methods for the analysis of longitudinal data.

  1992cited by this paper
• Respiratory mucus from asymptomatic smokers is better hydrated and more easily cleared by mucociliary action.

  1992cited by this paper
• Extracellular ATP and UTP induce chloride secretion in nasal epithelia of cystic fibrosis patients and normal subjects in vivo.

  1992cited by this paper
• Control of the beat cycle of respiratory tract cilia by Ca2+ and cAMP.

  1992cited by this paper
• Regulation of Cl- channels in normal and cystic fibrosis airway epithelial cells by extracellular ATP.

  1992cited by this paper
• Evidence that UTP and ATP regulate phospholipase C through a common extracellular 5'-nucleotide receptor in human airway epithelial cells.

  1991cited by this paper
• Regulation of transepithelial ion transport and intracellular calcium by extracellular ATP in human normal and cystic fibrosis airway epithelium

  1991cited by this paper
• Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis.

  1991cited by this paper
• A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.

  1990cited by this paper
• Cough-enhanced mucus clearance in the normal lung.

  1990cited by this paper
• Comparison of pulmonary and systemic effects of adenosine triphosphate in chronic obstructive pulmonary disease--ATP: a pulmonary controlled vasoregulator?

  1990cited by this paper
• Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.

  1990cited by this paper
• Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma.

  1986cited by this paper
• Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects.

  1983cited by this paper
• Random-effects models for longitudinal data.

  1982cited by this paper

• Mucoactive drugs and multiple applications in pulmonary disease therapy.

  2023cites this paper
• Mucus Release and Airway Constriction by TMEM16A May Worsen Pathology in Inflammatory Lung Disease

  2021cites this paper
• Mucociliary Clearance in Mice Measured by Tracking Trans-tracheal Fluorescence of Nasally Aerosolized Beads

  2018cites this paper
• United States Patent ( 10 ) Patent No . : US 7 , 618 , 949 B 2

  2017cites this paper
• mucociliary clearance through ENaC inhibition Linking increased airway hydration, ciliary beating, and

  2016cites this paper
• Linking increased airway hydration, ciliary beating, and mucociliary clearance through ENaC inhibition.

  2015cites this paper
• Duration of action of hypertonic saline on mucociliary clearance in the normal lung.

  2015cites this paper
• Therapeutic Options for Hydrating Airway Mucus in Cystic Fibrosis

  2015cites this paper
• Linking Increased Airway Hydration, Ciliary Beating

  2014cites this paper
• MULTI-COMPONENT MICROPARTICULATE/NANOPARTICULATE DRY POWDER INHALATION AEROSOLS FOR TARGETED PULMONARY DELIVERY

  2014cites this paper
• Multisite Comparison of Mucociliary and Cough Clearance Measures Using Standardized Methods

  2013cites this paper
• New pulmonary therapies directed at targets other than CFTR.

  2013cites this paper
• Role of mucolytics in wet cough.

  2013cites this paper
• The function of mucins in the COPD airway

  2013cites this paper
• Dust exposure is associated with increased lung function loss among workers in the Norwegian silicon carbide industry

  2013cites this paper
• Adenosine Triphosphate

  2012cites this paper
• Nasal potential difference measurements to assess CFTR ion channel activity.

  2011cites this paper
• Controlled Transport for Pulmonary Drug Delivery

  2011cites this paper
• New clinical diagnostic procedures for cystic fibrosis in Europe.

  2011cites this paper
• Mucoactive drugs

  2010cites this paper
• Dust exposure assessed by a job exposure matrix is associated with increased annual decline in FEV1: a 5-year prospective study of employees in Norwegian smelters.

  2010cites this paper
• Adjunctive and Supportive Measures for Community-Acquired Pneumonia

  2010cites this paper
• Osmolytes and ion transport modulators: new strategies for airway surface rehydration.

  2010cites this paper
• Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus.

  2009cites this paper
• Adenosine receptors, cystic fibrosis, and airway hydration.

  2009cites this paper
• Studies on antibiotic aerosols for inhalation in cystic fibrosis

  2009cites this paper
• P2Y-2 Receptor

  2008cites this paper
• Hydrator therapies for cystic fibrosis lung disease

  2008cites this paper
• Regulated airway goblet cell mucin secretion.

  2008cites this paper
• Denufosol: a review of studies with inhaled P2Y(2) agonists that led to Phase 3.

  2008cites this paper
• Evidence for airway surface dehydration as the initiating event in CF airway disease

  2007cites this paper
• Epithelial Sodium Channels in the Adult Lung – Important Modulators of Pulmonary Health and Disease

  2007cites this paper
• Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis.

  2007cites this paper
• Extracellular nucleotides regulate CCL20 release from human primary airway epithelial cells, monocytes and monocyte‐derived dendritic cells

  2007cites this paper
• Agonist-promoted regulation of the P2Y1 receptor: Quantification of native and recombinant receptors with the novel radioligand [32P]MRS2500

  2007cites this paper
• Relationships between cystic fibrosis transmembrane conductance regulator, extracellular nucleotides and cystic fibrosis.

  2006cites this paper
• E-NTPDases in human airways: Regulation and relevance for chronic lung diseases

  2006cites this paper
• Activation of human eosinophils via P2 receptors: novel findings and future perspectives

  2006cites this paper
• New Pharmacological Approaches for Treatment of Cystic Fibrosis

  2006cites this paper
• International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy

  2006cites this paper
• Novel, mechanism-based therapies for cystic fibrosis

  2005cites this paper
• Overview of the P2 receptors.

  2005cites this paper
• Airway responses to aerosolized brevetoxins in an animal model of asthma.

  2005cites this paper
• Cystic fibrosis.

  2005cites this paper
• Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: Results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis

  2005cites this paper
• fibrosis airway epithelia transport and improves fluid dynamics in cystic + Inositol polyphosphate derivative inhibits Na

  2005cites this paper
• Overview of the P2 Receptors

  2005cites this paper
• mechanisms of disease Cystic Fibrosis

  2005cites this paper
• Inositol polyphosphate derivative inhibits Na+ transport and improves fluid dynamics in cystic fibrosis airway epithelia.

  2005cites this paper
• Modulation of mucociliary function by drugs and other agents

  2004cites this paper
• Nucleotide-mediated inhibition of alveolar fluid clearance in BALB/c mice after respiratory syncytial virus infection.

  2004cites this paper
• Activation of airway cl- secretion in human subjects by adenosine.

  2004cites this paper
• Lung function changes in workers exposed to cobalt compounds: a 13-year follow-up.

  2004cites this paper
• Ionic interaction of amiloride and uridine 5'-triphosphate in nebulizer solutions.

  2004cites this paper
• Regulation of airway surface liquid volume and mucus transport by active ion transport.

  2004cites this paper
• Metabolism of P2 Receptor Agonists in Human Airways

  2004cites this paper
• Relationship of airway epithelial ion transport to chronic bronchitis.

  2004cites this paper
• Modelling growth and decline in lung function in Duchenne's muscular dystrophy with an augmented linear mixed effects model

  2004cites this paper
• Pharmacological Approaches to Correcting the Ion Transport Defect in Cystic Fibrosis

  2003cites this paper
• P2Y receptor specific for diadenosine tetraphosphate in lung: selective inhibition by suramin, PPADS, Ip5I, and not by MRS-2197.

  2003cites this paper
• Aerosol treatment of cystic fibrosis.

  2003cites this paper
• Increasing concentration of inhaled saline with or without amiloride: effect on mucociliary clearance in normal subjects.

  2003cites this paper
• Pharmacotherapy of the Ion Transport Defect in Cystic Fibrosis

  2003cites this paper
• Airway Retention of Materials of Different Solubility following Local Intrabronchial Deposition in Dogs

  2003cites this paper
• Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy.

  2002cites this paper
• Mucus clearance as a primary innate defense mechanism for mammalian airways.

  2002cites this paper
• Effects of extracellular triphosphate nucleotides and nucleosides on airway smooth muscle cell proliferation.

  2002cites this paper
• Les récepteurs P2Y des nucléotides extracellulaires : du clonage à la physiologie

  2002cites this paper
• Cystic fibrosis and CFTR

  2001cites this paper
• IBC’s 11th Annual International Symposium: Advances in Anticoagulant, Antithrombotic and Thrombolytic Drugs

  2001cites this paper
• P2 Receptors in the Respiratory System

  2001cites this paper
• Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: Results of a phase I multi‐center study

  2001cites this paper
• Uridine and Pyrimidine Nucleotides in Cell Function

  2001cites this paper
• P2Y Receptor Agonists

  2001cites this paper
• Pharmacotherapy Of The Ion Transport Defect In Cystic Fibrosis

  2001cites this paper
• The medicinal chemistry of the P2 receptor family.

  2001cites this paper
• Novel mechanistic targets for the treatment of sub-acute and chronic bronchitis.

  2001cites this paper
• Purinergic and Pyrimidinergic Signalling I

  2001cites this paper
• Clinical and pharmacological experience with LJP-394

  2001cites this paper
• Physiological evidence for a P2Y receptor responsive to diadenosine polyphosphates in human lung via Ca(2+) release studies in bronchial epithelial cells.

  2001cites this paper
• Ocular Safety of INS365 Ophthalmic Solution: A P2Y2 Agonist In Healthy Subjects

  2001cites this paper
• Therapeutic approaches to respiratory diseases excluding asthma:Trends from the patent literature 1997 - 2000

  2001cites this paper
• Chapter 7. Progress in the treatment of pulmonary disease in cystic fibrosis

  2001cites this paper
• Pharmacological treatment of the ion transport defect in cystic fibrosis

  2001cites this paper
• Validity and safety of sputum induction by inhaled uridine 5'-triphosphate.

  2001cites this paper
• Effect of aerosolized uridine 5'-triphosphate on mucociliary clearance in mild chronic bronchitis.

  2001cites this paper
• Regional Deposition of Coarse Particles and Ventilation Distribution in Healthy Subjects and Patients with Cystic Fibrosis

  2001cites this paper
• G-protein-coupled receptors as targets for gene transfer vectors using natural small-molecule ligands

  2000cites this paper
• Advances in signalling by extracellular nucleotides. the role and transduction mechanisms of P2Y receptors.

  2000cites this paper
• Increased circulating levels of plasma ATP in cystic fibrosis patients.

  2000cites this paper
• Modifying Factors of Cystic Fibrosis Disease: Residual Chloride Secrefion, Genefic Background and Epigenetics

  2000cites this paper
• PULMONARY EPITHELIAL SODIUM-CHANNEL DYSFUNCTION AND EXCESS AIRWAY LIQUID IN PSEUDOHYPOALDOSTERONISM

  2000cites this paper
• Sodium channel blockers and uridine triphosphate: effects on nasal potential difference in cystic fibrosis mice.

  2000cites this paper
• Basal Nucleotide Levels, Release, and Metabolism in Normal and Cystic Fibrosis Airways

  2000cites this paper
• INHALED ATP CAUSES MUCIN RELEASE FROM GOBLET CELLS OF INTACT RATS

  2000cites this paper
• French multicenter randomized double‐blind placebo‐controlled trial on nebulized amiloride in cystic fibrosis patients

  2000cites this paper
• Uridine and its nucleotides: biological actions, therapeutic potentials.

  1999cites this paper
• UTP inhibits Na+ absorption in wild-type and DeltaF508 CFTR-expressing human bronchial epithelia.

  1999cites this paper
• Pseudomonas aeruginosa Quorum-Sensing Signal Molecule N-(3-Oxododecanoyl)-l-Homoserine Lactone Inhibits Expression of P2Y Receptors in Cystic Fibrosis Tracheal Gland Cells

  1999cites this paper
• Pathogenesis of cystic fibrosis airways disease.

  1999cites this paper